-
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from Analysts
Source: Buzz FX / 01 Feb 2025 02:51:09 America/New_York
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat February 1, 2025 Share Link copied to clipboard. Madrigal Pharmaceuticals, Inc.
Read more...